PUTRAJAYA: Malaysia has signed an agreement with Merck Sharp & Dohme (MSD) to procure antiviral medicine Molnupiravir for Covid-19 treatment.
Health Minister Khairy Jamaluddin said the government signed a letter of undertaking on Thursday (Oct 7) to procure 150,000 courses of Molnupiravir to treat Covid-19 patients.
Already a subscriber? Log in.
Subscribe now for a chance to win your dream holiday!
![](https://cdn.thestar.com.my/Themes/img/sub_paywall_TSM.webp)
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!